Edited

“Polk said the planned Phase 3 clinical trial is a $100 million project – those funds are often drops in the bucket for larger pharmaceutical companies and those backed by venture capitalists“

I share this quote for all the shorts who notoriously bashed me about how rare it is for 100 million dollar to be handed out during trials or partnerships. This was just from venture capitalists raises.

My point is, we could easily see 200-300 million for one indication and some royalties handed out for a major phase 3 trial or we can raise money again.

Investors Hangout: https://investorshangout.com/post/view?id=666...z8PYLKykQX